Canada vs United Arab Emirates: Antiretroviral therapy coverage
Canada
76.0%
in 2022
United Arab Emirates
77.0%
in 2024
Canada rank
61st
United Arab Emirates rank
59th
Antiretroviral therapy coverage over time
- Canada
- United Arab Emirates
How they compare
United Arab Emirates currently reports 77.0% against 76.0% in Canada, a difference of 1.0%.
The two have swapped places 3 times across 23 shared years of data; in 2000 it was Canada ahead.
Canada ranks 61st and United Arab Emirates ranks 59th of 143 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.7% | 19.0% | 11.7% | Canada |
| 2010s | 64.2% | 27.1% | 37.1% | Canada |
| 2020s | 77.7% | 71.0% | 6.7% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage, Canada or United Arab Emirates?
- United Arab Emirates, at 77.0% against 76.0% in Canada as of 2024.
- What is the difference in antiretroviral therapy coverage between Canada and United Arab Emirates?
- 1.0%, with United Arab Emirates ahead.
- How many years of comparable data are there for Canada and United Arab Emirates?
- 23 years are reported by both, from 2000 to 2022.
- How do Canada and United Arab Emirates rank globally for antiretroviral therapy coverage?
- Canada ranks 61st and United Arab Emirates ranks 59th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.